Sultan Ullah’s Post

View profile for Sultan Ullah, graphic

Postdoctoral Research Associate with expertise in Medicinal and Pharmaceutical Chemistry

The researchers from China developed for the first time a protein degrader called #MtPTAC to facilitate targeted protein degradation inside #mitochondria. They successfully degraded the tumor progression regulator, #POLRMT, leading to significant tumor-suppressive effects both in vitro and in vivo. This modular system for mitochondrial protein proteolysis provides a platform strategy for designing targeted degradation agents. It represents the first modular targeted degradation technique based on the protease system in eukaryotic cells. Compared to traditional small-molecule inhibitors, MtPTAC completely blocks the functions of POLRMT, regardless of enzyme activity dependence. This makes it a promising prospect for cancer treatment and potential therapeutic strategies for various diseases related to abnormal mitochondrial protein expression. https://lnkd.in/e_EYHYKJ #protien #research #drugdiscovery #chemistry #JACS #medicinalchemistry

  • No alternative text description for this image
Sonali Das

Domain expert in drug discovery R & D for meaningful integration of biology & bioinformatics

1y

Activation of  hydrolase activity of ClpP by MtPTAC is an interesting MOA indeed.

Like
Reply

To view or add a comment, sign in

Explore topics